1. Home
  2. Labeler Index
  3. Novartis Pharma Stein Ag
  4. 17088-0219
  5. NDC Package Code: 17088-0219-1 Fingolimod Hcl

NDC Package 17088-0219-1 Fingolimod Hcl

Capsule - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
17088-0219-1
Package Description:
25000 CAPSULE in 1 DRUM
Product Code:
17088-0219
Non-Proprietary Name:
Fingolimod Hcl
Substance Name:
Fingolimod Hydrochloride
Usage Information:
This medication is used to treat multiple sclerosis-MS. It is not a cure for MS but it is thought to help by preventing immune system cells (lymphocytes) from attacking the nerves in your brain and spinal cord. It helps decrease the number of episodes of worsening and may prevent or delay disability.
11-Digit NDC Billing Format:
17088021901
Product Type:
Human Prescription Drug
Labeler Name:
Novartis Pharma Stein Ag
Dosage Form:
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Active Ingredient(s):
FINGOLIMOD HYDROCHLORIDE .5 mg/1
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
09-21-2010
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 17088-0219-1?

The NDC Packaged Code 17088-0219-1 is assigned to an UNFINISHED drug package of 25000 capsule in 1 drum of Fingolimod Hcl, a human prescription drug labeled by Novartis Pharma Stein Ag. The product's dosage form is capsule and is administered via form.

Is NDC 17088-0219 included in the NDC Directory?

Yes, Fingolimod Hcl is an UNFINISHED PRODUCT with code 17088-0219 that is active and included in the NDC Directory. The product was first marketed by Novartis Pharma Stein Ag on September 21, 2010 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 17088-0219-1?

The 11-digit format is 17088021901. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-117088-0219-15-4-217088-0219-01